There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC C07K16/2827
Pages in category "CPC C07K16/2827"
The following 71 pages are in this category, out of 71 total.
1
- 18277926. SINGLE DOMAIN ANTIBODY AGAINST PD-L1 AND USE THEREOF simplified abstract (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 18294767. METHODS TO ENHANCE EFFICACY OF COMBINED TARGETING OF IMMUNE CHECKPOINT AND MAPK PATHWAYS (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18705452. BUTYROPHILIN (BTN) 3A ACTIVATING ANTIBODIES FOR USE IN METHODS FOR TREATING INFECTIOUS DISORDERS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)
- 18709427. METHODS TO ENHANCE THERAPEUTIC EFFICACY IN MELANOMA VIA MODULATION OF CELL SURFACE PD-L1/L2 (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18951146. BISPECIFIC HUMANIZED SINGLE DOMAIN ANTIBODY TO PD-L1 AND CD47, AND USE THEREOF (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 19002153. DUAL SPECIFICITY ANTIBODIES TO PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM)
2
- 20250154259. Novel Methods Of Therapy (BIVICTRIX LIMITED)
- 20250163157. Bispec (Boehringer Ingelheim International)
- 20250171542. Anti-programmed Death- (Adept Therapeutics .)
- 20250179185. Anti-trem1 Ant (Pionyr Immunotherapeutics, .)
- 20250179186. Anti-b7 (REGENTS OF THE UNIVERSITY OF MINNESOTA)
- 20250179187. Anti Pd-l (REJUVERON SENESCENCE THERAPEUTICS AG)
- 20250188166. Il-18 Polypeptides (BRIGHT PEAK THERAPEUTICS AG)
- 20250188167. Antibodies (Nanjing Probio Biotech ., .)
- 20250188168. Treatment (THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES)
- 20250215089. Antigen-bin (HARBOUR BIOMED (SHANGHAI) .,)
- 20250230244. Methods Compositions Comprising B7-h3 Binding Polypeti (Board of Regents, The University of Texas System)
- 20250230245. Fusion Poly (ADLAI NORTYE BIOPHARMA ., .)
A
B
C
D
G
H
I
J
R
S
T
- TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent Application Trends in 2024
- THE ASAN FOUNDATION Patent Application Trends in 2025
- The Board of Trustees of the Leland Stanford Junior University Patent Application Trends in 2024
- The Johns Hopkins University Patent Application Trends in 2024
- The Methodist Hospital Patent Application Trends in 2025
- The regents of the university of california (20250066480). METHODS TO ENHANCE EFFICACY OF COMBINED TARGETING OF IMMUNE CHECKPOINT AND MAPK PATHWAYS
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024
- The Regents of the University of California Patent Application Trends in 2025
- The Regents of The University Of California Patent Application Trends in 2025
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on February 27th, 2025
- The Regents of the University of Colorado, a Body Corporate Patent Application Trends in 2025
- Trustees of Dartmouth College Patent Application Trends in 2024
- TRUSTEES OF DARTMOUTH COLLEGE Patent Application Trends in 2025
- Trustees of Dartmouth College Patent Application Trends in 2025